CSMBMEET2023

Dr. S.Y. Seong, M.D., Ph.D. in Microbiology and Immunology, now is a Professor and Ex Director of Wide River Institute of Immunology, Seoul National University College of Medicine. He got Ph.D. in Microbiology and Immunology in Seoul National University College of Medicine in 1995. He got Hamchun Medical Award, award of International Conference on Inante Immunity in Greece, the best poster award of DC 2007 in Germany in 2007, Yuhan Medical Award, Seoul Medical Association in 2012 etc. He is also the member of Korean Society for Microbiology, Korean Society for Immunology, American Society for Microbiology, and American Society for Immunology. He was a president of Korean Society for Dendritic cells and secretary of International DAMPs association. He suggested DAMPs model for the first time on Nature Rev. Immunology in 2004, which brought novel insight of modern innate immunology. He is now working on development of new therapeutics for COVID-19, atopic dermatitis and Alzheimer disease based on DAMPs model. He found that GPCR19 agonists could ameliorate inflammation not only in preclinical models but also in phase 2 clinical trials. He has also worked on development of nanobodies in immuno-oncology fields.

Zeliha Selamoglu is a Professor in Medical Biology department of Ömer Halisdemir University, Turkey. She completed her PhD in Biology from Inonu University. She has published over 70 peer reviewed journal articles with over 500 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine. She has served as an Editorial Board Member for many Journals

Dr. Blagg received a B.A. in Chemistry and Environmental Studies from Sonoma State University in 1994. He then went on to earn a Ph.D. in organic chemistry from the University of Utah in the laboratory of Dale Poulter. Following the completion of his Ph.D., he was a NIH postdoctoral fellow at the Scripps Research Institute, wherein he studied in Dale Boger's laboratory until 2002. Dr. Blagg began his independent research career as a medicinal chemistry professor at The University of Kansas, where he remained until 2017. In 2017, Dr. Blagg became the director of the Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame and the Charles Huisking Professor of Chemistry and Biochemistry. His research focuses on the design, synthesis, and evaluation of HSP90 inhibitors.

Richard Denk has studied mechanical engineering and did examination on Experts of GMP, Qualification and Validation, Pharmaceutical Auditing, Pharmaceutical Engineering, Quality Control on the University of Applied Sciences in Albstadt/Sigmaringen Germany. Richard Denk is working at the company SKAN AG, headquartered in Allschwil CH in the position Head Containment. Mr. Denk founded 10 years ago the expert Containment group CoP of the ISPE D / A / CH. The ISPE CoP Containment published the ISPE Containment Manual in September 2015. The ISPE Containment Manual does provide a full overview on Containment. Furthermore, Mr. Denk is author at Maas & Peither GMP Publishing on containment and hygienic design and one of the authors of the ISPE Oral Solid Dosage Baseline Guide Volume 2 and Volume 3. Mr. Denk has spent more than 20 years with the subject production of highly active / highly hazardous substances and has developed the containment pyramid.

Dr Carlos Orozco is a scientist, author, speaker and lecturer whose diverse scientific career includes professional training in Biochemistry, Immunology, Biophysics, Epigenetics, Reproductive Medicine, Reproductive Biology, Orthomolecular Medicine, Traditional Chinese Medicine, Integrative Medicine, Quantum Physics, and Quantum Biology. An Australian University offered Dr Carlos a PhD scholarship to move from Mexico. He has since gone on to author the book ‘Key to Coherence’ and is the inventor of a method and product which creates a quantum morphic energy field all of which he calls the ‘Symphony of Love.’ He holds a Bachelor of Science Degree in Experimental Biology, majoring in Biochemistry and Biophysics, a Masters Degree in Immunology, and a PhD in Biochemistry, with a further 5 years as a Postdoctoral Fellow. He specialised in Reproductive Medicine, and Reproductive Biology, Gynaecological Oncology, Clinical Nutrition, and Traditional Chinese Medicine. He is the International Vice President of the ‘World Association for Excellence in Health’ (AMES Mundial), he operates from Australia and joined our advisory board in 1-2022.

Prof. Sinerik Ayrapetyan has received his PhD in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev during the period of 1966-1970. Currently, he is the coordinator of UNESCO Chair at Life Sciences International Postgraduate Educational Center, Yerevan, Armenia. His research has included the study of metabolic regulation of cell function in norm and pathology. He is serving as a Chief Editor for the Journal of “Bioequivalence and Bioavailability”, and an editorial member of several reputed journals like “Electromagnetic Biology and Medicine”, “ISRN Biophysics”, “European Journal of Biophysics”, “Advances in Life Sciences", “Applied Pharmacy”, “BBA General Subjects”, “International Dental and Medical Research", “International Journal of Basic and Applied Sciences”, “Insights of Medical Sciences”, “Chronicles of Pharmaceutical Science Journal”, “Clinical Investigations”, “Global Drugs and Therapeutics” etc. Prof. Sinerik Ayrapetyan is a member of a number of international societies, such as International Society of Invertebrate Neurobiology (ISIN), International Society for neurochemistry (ISN), European Society for Neurochemistry (ESN), International Brain Research Organization (IBRO), International Union of Pure and Applied Biophysics (IUPAB), Bioelectromagnetics Society (BEMS), WHO International Advisory Committee on Electromagnetobiology and the president of “All Armenian Research Council”. He has authored 7 international books and 115 research articles.

Thomas J. Webster’s (H index: 116; Google Scholar) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has served as a professor at Purdue (2000-2005), Brown (2005-2012), and Northeastern (2012-2021; serving as Chemical Engineering Department Chair from 2012 - 2019) Universities and has formed over a dozen companies who have numerous FDA approved medical products currently improving human health. He is currently helping those companies and serves as a professor at Hebei University of Technology, Saveetha University, Vellore Institute of Technology, UFPI, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies.Prof. Webster is a former President of the U.S. Society For Biomaterials and has over 1,350 publications to his credit with over 53,000 citations. He was recently nominated for the Nobel Prize in Chemistry (2023).

Recognised as a world leading Expert in consumer Corona Cold Air Plasma Medicine medical devices using Quantum Physics for therapeutic benefits across the biological systems of the human body and blood. For ongoing live research without excluding any patients she has commenced a decentralised hybrid clinical case study unit for all willing participants. Recently advancing the original technology she patented the world’s first “systemic selective adaptogen” using non-equilibrium atmospheric air to work alongside pharmaceuticals and vaccines without interference or alone. “It’s a physics solution to human health for any age, not a chemical solution.” Her patient results have inspired scientists around the world, today she is in demand speaking internationally since her return from Wuhan 3-2020, including to the United Nations science committee in 2021. She has 10 years’ experience across 38 multidisciplinary scientific and medical fields as an Independent Scientist; following 16 years of academic training with an impressive 30 year career as an International Chief Executive across 17 countries; including 9.5 years in Fortune 50 companies and International diplomacy. She’s a ‘humanitarian, on a mission to improve global health systemically.’

Michael B. Fossel, M.D., Ph.D. (born 1950, Greenwich, Connecticut) is a former professor of clinical medicine at Michigan State University and is the author of several books on aging, who is best known for his views on telomerase therapy as a possible treatment for cellular senescence. Fossel has appeared on many major news programs to discuss aging and has appeared regularly on National Public Radio (NPR). He is also a respected lecturer, author, and the founder and former editor-in-chief of the Journal of Anti-Aging Medicine (now known as Rejuvenation Research).[citation needed] Prior to earning his M.D. at Stanford Medical School, Fossel earned a joint B.A. (cum laude) and M.A. in psychology at Wesleyan University and a Ph.D. in neurobiology at Stanford University. He is also a graduate of Phillips Exeter Academy. Prior to graduating from medical school in 1981, he was awarded a National Science Foundation fellowship and taught at Stanford University.[citation needed] In addition to his position at Michigan State University, Fossel has lectured at the National Institute for Health, the Smithsonian Institution, and at various other universities and institutes in various parts of the world. Fossel served on the board of directors for the American Aging Association and was their executive director

Alain Chapel For 25 years, he has been developing gene and cell therapy using non-human primates, immune-tolerant mice and rats to protect against the side effects of radiation. He collaborates with clinicians to develop strategies for treatment of patients after radiotherapy overexposures. He has participated in the first establishment of proof of concept of the therapeutic efficacy of Mesenchymal stem cells (MSCs) for the treatment of hematopoietic deficit, radiodermatitis and over dosages of radiotherapy. He has contributed to the first reported correction of deficient hematopoiesis in patients (graft failure and aplastic anemia) thanks to intravenous injection of MSCs restoring the bone marrow microenvironment, mandatory to sustain hematopoiesis after total body irradiation. He is scientific investigator of Clinical phase II trial evaluating the efficacy of systemic MSC injections for the treatment of severe and chronic radiotherapy-induced abdomino-pelvic complications refractory to standard therapy

Professor Stefan Glück, MD, PhD, FRCPC is V.P of Global Medical Affairs, at Celgene Corporation since October 2014, and a medical oncologist with focus on breast cancer. He has overseen breast, ovarian, pancreatic and bladder cancer activities worldwide, as well as the Immuno-Oncology Program in solid tumors. Recently, his job requirements have shifted to include all solid tumors and most importantly Early Assets. He previously served as a Sylvester Professor in the Department of Medicine at Miller School of Medicine, University of Miami, Florida until September 2014. From 2003–2008, he was the Clinical Director of the Braman Family Breast Cancer Institute, and from January 2009 - December 2010 Assistant Director of the Sylvester Comprehensive Cancer Center and Associate Chief, Division Hematology & Medical Oncology. He has been a PI of 37 clinical studies of breast cancer in Miami, as well as investigator in numerous scientific, translational projects. He has authored or co-authored over 270 articles. In addition, Dr Glück has written or co-written several book chapters and numerous journal abstracts, and has presented more than 380 papers at national and international meetings.

Dolashka’s group has wide experience in the isolation, purification, and characterization of biologically active compounds. She has more than 130 publications on these topics, 3 book chapters and 7 patents. Prof. Dolashka is Editor-in-board of 3 journals and representative IUPAC. She is coordinating several international research projects, sponsored by NATO (Brussels), the European Commission, Germany (DFG and BMBF), CNR (Italy), FWO (Belgium), China, and Ukraine. She also participates in BG05M2OP001-1.002-0019: "Clean Technologies for Sustainable Environment - Water, Waste, Energy for Circular Economy". Total value: 23667925.86 lv (20117736.97 European and 355018.89 lv national co-financing).

Andrey Sorokin graduated from the St. Petersburg State University and received his Ph.D. from the Institute of Cytology Academy of Sciences of Russia in 1981. A. Sorokin is a Head of the Laboratory at the Medical College of Wisconsin, where he is holding the position of Full Professor of Medicine with secondary appointments at Department of Physiology and Department of Microbiology & Immunology. He has published more than 100 papers in reputed journals and is serving as an editorial board member of a number of journals including Frontiers in Renal and Epithelial Physiology.

Sergey Suchkov was born in the City of Astrakhan, Russia, in a dynasty of medical doctors, graduated from Astrakhan State Medical University and was awarded with MD. Then maintained his PhD and Doctor’s Degree. And later was working for Helmholtz Eye Research Institute and Moscow Regional Clinical Research Institute (MONIKI). Dr Suchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is: (i) Scientific Director of the Institute of Global Health. (ii) Chair of Dept. for Personalized Medicine and Precision Nutricology of MGUPP. (iii) Professor, Dept. for Clinical Immunology, A.I. Evdokimov MGMSU, Russia. (iv) A Member, New York Academy of Sciences, USA.

Huang Wei Ling has completed her Graduation in Medicine in Londrina State University. She is Specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. She was the In-charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, responsible for the control of all prescribed antimicrobial medication

Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company Wright-Wold Scientific, the pharmaceutical company CTE cure, and was a science advocate on Capitol Hill through the Washington Fellow’s program.

Zeliha Selamoglu is a Professor in Medical Biology department of Ömer Halisdemir University, Turkey. She completed her PhD in Biology from Inonu University. She has published over 70 peer reviewed journal articles with over 500 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine. She has served as an Editorial Board Member for many Journals

Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. Prior, he was an Erasmus Student at Faculté de Pharmacie de Reims in Reims, France. He received his Doctor Europaeus in 2010 from Pitié-Salpétrière Institute in Paris, France. Also in 2010, he received his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at G. d’Annunzio University in Chieti-Pescara, Italy. He was hired as a Postdoctoral Scholar in the Department of Pharmacology and Physiology at the University of South Florida in Tampa, on two research grants funded by the Office of Naval Research (US Navy) and Divers’ Alert Network. He has written and lectured widely worldwide. He has been involved in ongoing research at the University of South Florida with the use of ketone esters.

Dr. Kalliopi Megari is an experienced psychologist working in the hospital & health care industry. She is a lecturer at University of Western Macedonia in Greece. Skilled in Clinical Neuropsychology, Clinical Research and Learning Disabilities. Graduated from Aristotle University of Thessaloniki and attended further education from University of Macedonia, in people with special needs and disabilities. She holds undergraduate degrees in Nursing and Psychology, as well as a Master’s and a PhD in Neuropsychology from Aristotle University of Thessaloniki. She has many years of experience working with chronic disease patients as well with people with disabilities. Her work has earned her many prestigious international awards. She has given lectures at Aristotle University of Thessaloniki and University of Warsaw. She is postdoctoral researcher and has published more than 10 research articles in journals. She is the Global Engagement Representative of International Neuropsychological Society, General Secretary of the booard of directors and member of the Ethics Committee of Hellenic Neuropsychological Society.

Inga Urlić, PhD, works as a professor associate at the Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb. Her research field is biomedicine with a focus on tumor biology, stem cell biology and tissue engineering - bone and cartilage regeneration. She is the principal investigator of 3 competitive research projects (MZOS, BICRO, HRZZ), 2 research donations (HAZU, HEP), 1 R&D project and the group leader within 1 Horizon2020 project. She is a co-author of 42 scientific papers, 53 abstracts and invited speaker at three international conferences. She is lecturing five courses - Mutagenesis and Carcinogenesis, Research Methods in Molecular Biology, Stem Cell Biology, Introduction to Forensic Biology and Workshops in Cell and Molecular Genetics. She mentored more than 20 graduate students and 8 doctoral theses. She is active as a project evaluator and reviewer for scientific journals and member of several professional associations – Tissue engineering and regenerative medicine society, European association for cancer research, International society for applied biological sciences and Croatian biological society.

Associate Professor, Dr. AleksandarDolashki works at laboratory "Chemistry and Biophysics of proteins and enzymes" in Institute of Organic Chemistry with Centre of at the Bulgarian Academy of Sciences. His scientific interests include the isolation, characterization and application of bioactive substances from natural sources, mainly proteins, glycoproteins and antimicrobial as well as studying their mechanism of action. In the studies, she uses different chromatographic and spectral methods, mass spectrometry, proteomic analysis and bioinformatics. Assoc. Prof. Dr. AleksandarDolashki participates in many national and international research projects and he is co-author of over 60 papers.

Dr. Yan Leyfman, MD, has been recognized as one of the top international researchers in oncology by ASH and ASCO. During the COVID-19 pandemic, he was recruited as the Director of the Immunology Division of the Global COVID-19 Taskforce, which produced one of the first mechanisms for SARS-CoV-2 and COVI-Flu along with therapeutic interventions for both. In 2021, Dr. Leyfman presented the first mechanism to explain the interplay between cancer and COVID-19 at the 2021 ASCO Annual Meeting. His work has been published as the cover article in the journal, Shock, and in the textbook, Insights on a Post-COVID World.

Associate Professor, Dr. Lyudmila Velkova works at laboratory "Chemistry and Biophysics of proteins and enzymes" in Institute of Organic Chemistry with Centre of at the Bulgarian Academy of Sciences. Her scientific interests include the isolation, characterization and application of bioactive substances from natural sources, mainly proteins, glycoproteins and antimicrobial as well as studying their mechanism of action. In the studies, she uses different chromatographic and spectral methods, mass spectrometry, proteomic analysis and bioinformatics. Assoc. Prof. Dr. L. Velkova participates in many national and international research projects and she is co-author of over 60 papers.

Irina V Guzhova graduated in St.Petersburg State University and received her PhD (1989) and Dr.Sci (2005) from the Institute of Cytology of Russian Academy of Sciences. The interests of the Guzhova’s lab lie in the field of the cell proteostasis systems. When applied to tumor cells, overactivated proteostasis leads to failure of antitumor therapy, to higher tumor aggressiveness as well as to tumor recurrence. Now Irina Guzhova is a Head of the Cell and Molecular Interaction Department, and vice-director of the Institute of Cytology of Russian Academy of Sciences. She is an author of more than 150 research publications

I studied Medical Surgeon at the Universidad Mayor and then I graduated as an Adult Neurologist at the University of Chile, I took the Electroencephalography and Epilepsy Fellowship at the Pontificia Universidad Catolica de Chile. I currently work as a teacher at the Finis Terrae University, Neurologist in epilepsy and electroencephalography, Neurology Polyclinic and in the Stroke Treatment Unit at the San Juan de Dios Hospital. I have published papers on Epilepsy and pregnancy as well as neurological sequelae in cranial brain trauma in patients with traffic accidents.

Prof. Ehud Razin received his B.Sc.in Biology and M.Sc. in Microbiology from the Hebrew University and his Ph.D. in Immunology from the Weizmann Institute of Science, Rehovot, Israel. Prof. Razin has for many years been a major contributor and leading scientist in the field of mast cell biology. In 1980, while most investigators used rat peritoneal mast cells as a model for study their function, he successfully developed a cultured mouse bone marrow derived system as a mast cells model1. This system still serves as the main tool for studying mast cell function. Prof. Razin’s long term goal has been to try to ascertain the regulation of gene transcription in mast cells due to their interaction with their growth factors and in response to trigger by immunological stimulus through their surface FCεRI receptors. His team has explored the relationship between aggregation of mast cell surface receptors and AP-1, USF2 and microphthalmia transcription factor (MITF) transcriptional activity. Prof. Razin continued to push the mast cell field ahead by discovering few years ago a new signaling pathway in mast cells and other cells which directly involved in gene regulation. His team observed that in variety of cells LysRS forms a complex with either MITF or USF2, while Ap4A produced by LysRS causes the release of Hint-1 from these two transcription factors. As Hint-1 suppresses the transcriptional activity of MITF and USF2 in these cells, Ap4A could act as a general regulator of the transcriptional activity of transcription factors belonging to the HLH family of proteins2 3. His team also researches the molecular mechanisms of the inhibition of MITF and STAT3 transcriptional activity by PIAS34 5 6. Other aspects of Prof. Razin’s mast cell research include the dependence of Bcl-2 on its association with HSP90β for its anti-apoptotic function in mast cells7. Recently Prof. Razin has added an exciting new direction to his laboratory’s research by investigating MITF’s functions in the heart8. A role of MITF in cardiac hypertrophy has being demonstrated and the cardiac isoforms of MITF have been characterized.

Dr Ghanem was qualified in 1968, Mansoura University, Egypt. He gained all postgraduate experience in UK where he was promoted in posts up to the consultant level. He practiced as consultant Urologist in UK, Saudi Arabia and Egypt. During his career life he reported over 60 articles of which he made important discoveries in medicine, physiology, urology, nephrology, cardiovascular and surgery. He discovered two new types of vascular shocks, proved that one physiological law is wrong and provided an alternative. He resolved the puzzles of 3 clinical syndromes; the transurethral of the prostate (TURP) syndrome, the loin pain haematuria syndrome (LPHS) and the adult respiratory distress syndrome (ARDS). He is now the Editor-in-Chief for The Surgical Medicine Open Access Journal (SMOAJ). Now he is happily retired in Egypt.

Dr. Yodoi is a Prof.Em. of Kyoto University and is the Chairman of JBPA (Japan Biostress Research Promotion Alliance). He was a Professor of in Department of Biological Responses, Insitute for Virus Research (IVR), Kyoto University, retiring in April 2010. After graduation from Kyoto University Medical School in 1971 and upon completing postgraduate courses in the University Hospital and the IVR, he was appointed as Assistant Professor in the Institute for Immunology in the Medical School. Between 1977-1980, Dr. Yodoi was a Research Associate in Johns Hopkins University Department of Medicine under Prof. Kimishige Ishizaka. After, he returned to Kyoto Univ. and was appointed as Professor in the Department of Prevention and Therapeutics, IVR in 1989, and the moved to the Department of Biological Responses in 1990. He was also appointed as the Human Stress Signal Research Center, Head of BioMedical Special Research Unit, AIST (National Inst Advanced Industrial Science and Technology Japan) from 2001 to 2004. He was also a group leader of Translational Res Center, Thioredoxin Project in Kyoto Univ. Hospital from 2003 to 2007.

Magnus S. Magnusson, PhD, Emeritus Research Professor, founder and director of the Human Behavior Laboratory (hbl.hi.is), University of Iceland. Author of the T-pattern, T-string and T-system model and the corresponding detection algorithms and software THEMETM (PatternVision.com), initially focusing on real-time organization of behavior. Co-directed DNA analysis. Numerous papers, talks and keynotes in ethology, neuroscience, mathematics, religion, proteomics, mass spectrometry, A.I., robotics and nanoscience. Deputy Director 1983-1988 in Museum of Mankind, National Museum of Natural History, Paris. Repeatedly invited Professor at the University of Paris, V, VIII and XIII in psychology and the biology of behavior. Now works in formal collaboration between 32 European and American universities initiated 1995 at the University Rene Descartes of Paris V, Sorbonne, based on “Magnusson’s analytical model”

She is currently affiliated with the Department of Medical Imaging in University of Dundee, Scotland, United Kingdom.She completed her Bachelor of Medicine and Bachelor of Surgery from Mahatma Gandhi Institute of Medical Sciences, Deemed University, Navi Mumbai, India. She completed her one year internship from Government approved Civil Hospital, Lucknow, India. Well versed with basic diagnostic and therapeutic procedures in all the medical departments. Worked as a Radiology assistant in India, has an in depth knowledge of Human Anatomy and Physics of common Radiological Machines such as CT scan, MRI, PET scan and X rays. Has worked as a volunteer in various health camps and NGO’s to provide free medicines , perform Imaging and check ups for the patients. Her major research work was in Stereotactic Ablative Radiotherapy treatment of lung cancer patients which was approved by Caldicott as well as R&D Tayside,United Kingdom. Worked in Radiotherapy Physics Department, Ninewells Hospital ,Dundee, United Kingdom for a tenure of two months to learn about the Stereotactic Ablative Radiotherapy planning and evaluation system in the Ray Station Treatment Planning system Ver. 11B (Ray search Laboratories,U.K.).

Ventseslav Atanasov is PhD student, who works at laboratory "Chemistry and Biophysics of proteins and enzymes" in Institute of Organic Chemistry with Centre of at the Bulgarian Academy of Sciences. His scientific interests include the isolation, characterization and application of bioactive substances from natural sources, mainly proteins, glycoproteins and antimicrobial peptides, as well as studying their mechanism of action through proteomic analysis.

Fernando Cardona holds a PhD in Molecular Biology from the University of Valencia. He has published 16 articles indexed in JCR and 9 indexed in Scopus, as well as a textbook and other teaching materials. He has participated in more than 30 international congresses. In addition, he has an intense editorial activity, having reviewed more than 130 articles indexed in JCR journals and acting as an editor for 34. He conducts his research activity at the Molecular Genetics Unit of the Institute of Biomedicine of Valencia (CSIC) and teaches at the Department of Biotechnology of the Polytechnic University of Valencia.

Huang Wei Ling has completed her Graduation in Medicine in Londrina State University. She is Specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. She was the In-charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, responsible for the control of all prescribed antimicrobial medication

Dr Tabinda Hasan is MBBS, MD, PGDHE(higher education) and PhD( Anatomy), is Assistant Professor in College of medicine, Riyadh, Saudi Arabia. She has 12 years teaching experience in anatomy and is proficient in Cadaveric Dissection and prosection, Video based case construction in Problem based learning, Research methodology, Research Ethics, Induced pleuripotent stem cell culturing techniques and Atomic force microscopy. She was awarded by Boston university school of medicine, USA(advancing ethical research award), Marie curie research award in anatomy for 2015 (with 5000 participants from over 80 countries), Stem cell unit, King Saud University ,KSA(Effective scientific vocalizations); OSDOW 2011 nominee, Elsevier, Trieste-Italy(women in science for developing world), Faculty of medicine &Health sciences, Saudi Arabia(excellence in Teaching award). She has headed the scientific committee for 3 consecutive years for Medical Research Day international conference , Saudi Arabia. She is a renowned author, with 38 Journal publications and 95 citations, 36 conference presentations including Masseuchets -USA, California, Germany, Venice-Italy, Bulgaria, Malaysia, Korea, Greece, Dubai, Abu-Dhabi, Qatar, India ,Saudi Arabia, Pakistan. She is a keen researcher and has served as principal investigator in several multinational research projects.

Dr. Yoshikazu Nakamura has served as RIBOMIC's President and CEO since 2012 when he retired from The University of Tokyo (currently Professor Emeritus). He founded the Company in 2003 when he was the UTokyo Professor at Institute of Medical Science. He has served the scientific community as the Vice President of A-IMBN since 2003, and the President of the RNA Society of Japan during 2006-2010. Throughout his academic career, Dr. Nakamura has been engaged in RNA science, and discovered a novel biological concept “molecular mimicry between protein and RNA” in 2000, which provided the basis of RIBOMIC’s R&D for aptamer therapeutics.

Dimitar Kaynarov is young researcher, PhD student, who works at laboratory "Chemistry and Biophysics of proteins and enzymes" in Institute of Organic Chemistry with Centre of at the Bulgarian Academy of Sciences. His scientific interests include the isolation, characterization and application of bioactive substances from natural sources, mainly proteins, glycoproteins and antimicrobial peptides, as well as studying their mechanism of action through proteomic analysis.